Hassan Kamali

1 ta ish

Tarbiat Moallem University of Tehran

1. Feasibility and Therapeutic Potential of 177Lu–Fibroblast Activation Protein Inhibitor–46 for Patients With Relapsed or Refractory Cancers

   Majid Assadi, Seyed Javad Rekabpour, Esmail Jafari +9

   Maqola20213 iqtibos

   ABIABI:AkademIndex/2026.other.340322